NCT06629207 · RECRUITING

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

This study is tracking people who have REM sleep behavior disorder — a condition where people act out their dreams — to see if brain scans analyzed by AI can predict who will go on to develop Parkinson's disease or a related condition called Lewy body dementia. It is a non-drug observational study, not a treatment trial, so it is about building better prediction tools, not testing a therapy.

Inclusion criteria

  • Confirmed clinical iRBD diagnosis by movement disorder specialists according to the International Classification of Sleep Disorders
  • Written informed consent

Exclusion criteria

  • Known diagnosis of PD or other neurodegenerative disorder
  • Unequivocal signs of parkinsonism on examination
  • Narcolepsy or other known causes of RBD
  • Moderate to severe obstructive sleep apnea
  • Abnormal neurological or MRI examination

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-11-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials